Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns.

Sack LM, Davoli T, Li MZ, Li Y, Xu Q, Naxerova K, Wooten EC, Bernardi RJ, Martin TD, Chen T, Leng Y, Liang AC, Scorsone KA, Westbrook TF, Wong KK, Elledge SJ.

Cell. 2018 Apr 5;173(2):499-514.e23. doi: 10.1016/j.cell.2018.02.037. Epub 2018 Mar 22.

2.

Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties.

Dasgupta A, Trucco M, Rainusso N, Bernardi RJ, Shuck R, Kurenbekova L, Loeb DM, Yustein JT.

Oncotarget. 2017 Aug 24;8(44):77292-77308. doi: 10.18632/oncotarget.20467. eCollection 2017 Sep 29.

3.

The spliceosome is a therapeutic vulnerability in MYC-driven cancer.

Hsu TY, Simon LM, Neill NJ, Marcotte R, Sayad A, Bland CS, Echeverria GV, Sun T, Kurley SJ, Tyagi S, Karlin KL, Dominguez-VidaƱa R, Hartman JD, Renwick A, Scorsone K, Bernardi RJ, Skinner SO, Jain A, Orellana M, Lagisetti C, Golding I, Jung SY, Neilson JR, Zhang XH, Cooper TA, Webb TR, Neel BG, Shaw CA, Westbrook TF.

Nature. 2015 Sep 17;525(7569):384-8. doi: 10.1038/nature14985. Epub 2015 Sep 2.

4.

A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, Yu B, Hsu T, Golding I, Luo J, Osborne CK, Creighton CJ, Hilsenbeck SG, Schiff R, Shaw CA, Elledge SJ, Westbrook TF.

Science. 2012 Jan 20;335(6066):348-53. doi: 10.1126/science.1212728. Epub 2011 Dec 8.

5.

Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.

Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, Migliaccio I, Nguyen DX, Pavlova NN, Botero M, Huang J, Bernardi RJ, Schmitt E, Hu G, Li MZ, Dephoure N, Gygi SP, Rao M, Creighton CJ, Hilsenbeck SG, Shaw CA, Muzny D, Gibbs RA, Wheeler DA, Osborne CK, Schiff R, Bentires-Alj M, Elledge SJ, Westbrook TF.

Cell. 2011 Mar 4;144(5):703-18. doi: 10.1016/j.cell.2011.02.003.

6.

The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.

Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, Herschkowitz JI, Burrows AE, Ciccia A, Sun T, Schmitt EM, Bernardi RJ, Fu X, Bland CS, Cooper TA, Schiff R, Rosen JM, Westbrook TF, Elledge SJ.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70. doi: 10.1073/pnas.1019736108. Epub 2011 Feb 9.

7.

Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.

Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF, Aikin A, Whitcomb P, Renbarger J, Lieberman FS, Berg SL, Blaney SM.

Cancer Chemother Pharmacol. 2008 Jul;62(2):355-61. Epub 2007 Oct 2.

PMID:
17909804
8.

Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines.

Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JL.

J Neurooncol. 2008 Jan;86(2):165-72. Epub 2007 Sep 6.

PMID:
17805488
9.

Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments.

Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS, Trump DL.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):768-70. Review.

PMID:
17368191
10.

A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.

Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS.

Clin Cancer Res. 2007 Feb 15;13(4):1216-23.

11.

Anti-tumor activity of calcitriol: pre-clinical and clinical studies.

Trump DL, Hershberger PA, Bernardi RJ, Ahmed S, Muindi J, Fakih M, Yu WD, Johnson CS.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):519-26. Review.

PMID:
15225831
12.

Vitamin D receptor: a potential target for intervention.

Johnson CS, Hershberger PA, Bernardi RJ, Mcguire TF, Trump DL.

Urology. 2002 Sep;60(3 Suppl 1):123-30; discussion 130-1. Review.

PMID:
12231068
13.

Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells.

Bernardi RJ, Johnson CS, Modzelewski RA, Trump DL.

Endocrinology. 2002 Jul;143(7):2508-14.

PMID:
12072382
14.
15.

Development of a malignant peripheral nerve sheath tumor following treatment for testicular seminoma.

West DA, Parra RO, Manepalli A, Bernardi RJ, Cummings JM.

Urology. 1997 Aug;50(2):292-4.

PMID:
9255308
16.

Surgical management of nontuberculous thoracic and lumbar vertebral osteomyelitis: report of 33 cases.

Arnold PM, Baek PN, Bernardi RJ, Luck EA, Larson SJ.

Surg Neurol. 1997 Jun;47(6):551-61.

PMID:
9167780
17.

Warfarin-induced spondyloarthropathy with pseudotumor-like appearance. A case report.

Awwad EE, Bernardi RJ, Sundaram M.

Spine (Phila Pa 1976). 1996 Aug 15;21(16):1936-8.

PMID:
8875729
18.

Unusual fracture dislocation of the craniovertebral junction.

Awwad EE, Martin DS, Cheung KC, Bernardi RJ.

AJNR Am J Neuroradiol. 1995 May;16(5):1155-7. No abstract available.

Supplemental Content

Loading ...
Support Center